Monthly Archives: February 2021

First Patient Enrolled in Novel Pediatric Cancer Clinical Trial

LOS ANGELES (May 8, 2020) — Today, a USCCLA physician director has announced her intention to enroll in a clinical trial of no patients for pediatric cancer.

Aneesh Kamal, MD, PhD, director of the Marlan and Thomas Lovell Chair in Pediatric Genetics and Neurodevelopment, expects to enroll in trial participants from six California sites that will offer patients an FDA-approved compound, called VK1, to treat advanced or recurrent pediatric central nervous system tumors.

Continue reading